ASUNCION — Uruguay on Tuesday released real-world data on the impact of Sinovac Biotech’s COVID-19 vaccine among its population that showed it was over 90% effective in preventing intensive care admissions and deaths.
The shot reduced deaths by 95% and intensive care admissions by 92%, and also showed 61% efficacy in cutting coronavirus infections, the government said.
A total of 795,684 people – health workers and members of the general population between the ages of 18 and 69 – at least 14 days after receiving their second dose of Sinovac’s CoronaVac were compared to unvaccinated people to determine the real-world vaccine effectiveness, the government said in a report.
T…
Keep on reading: Sinovac, Pfizer-BioNtech COVID-19 vaccines prove highly effective in Uruguay — government